Stock Events

Stock Events

VYNE Therapeutics (VYNE) Q1 2026 Earnings

15MayConfirmed

Q3 2025

Q4 2025

Q1 2026

Q1 2026

-0.23

-0.18

-0.13

-0.08

Details

Expected EPS

-0.18

Actual EPS

-0.08

Surprise EPS

0.1

Surprise Percent

+55.56%

Description

VYNE Therapeutics (VYNE) has reported earnings of -0.08 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.